Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06951568

Study of the Effect of Peripheral Somatosensory Stimulation on the Functionality of Patients With Cerebral Palsy and Reduced Mobility

Cerebral palsy (CP) is a permanent neurological disorder that affects movement and posture, caused by an injury to the developing brain. It may also be accompanied by cognitive, hearing, and speech impairments, as well as epilepsy. Although it is a condition that manifests in childhood, its effects persist throughout life, posing specific challenges in mobility and functionality during adulthood. Although physiotherapy is a key component in the rehabilitation of children with CP and helps adults manage pain and improve motor function, many adults with CP do not receive the treatment they need. Barriers such as financial difficulties, transportation issues, and the lack of physiotherapists specialized in CP affect both access to and the quality of care. Even when physiotherapy is provided, adults with CP are often less satisfied with the services compared to children.The aim of this study is to promote the recovery of motor function in adults with cerebral palsy through sensory stimulation of the lower limbs, as part of an intensive motor rehabilitation program. This program seeks to foster autonomy in movements and transfers, as well as active participation in daily life activities.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pedro Victor López Plaza

Barcelona, Spain

Location status: Recruiting

Location contact

Ismael Ordoñez

SUB_INVESTIGATOR

Jessica Zamora

SUB_INVESTIGATOR

Lorenzo Escutia

SUB_INVESTIGATOR

Marta Cuadros

SUB_INVESTIGATOR

Pedro V López

CONTACT

[email protected]

932 53 32 56

Pedro Victor López Plaza

PRINCIPAL_INVESTIGATOR

About this study

Objective: To evaluate the impact of peripheral somatosensory stimulation on motor function in adults with cerebral palsy.

Methods: Experimental, crossover, and randomized. Each participant will serve as their own control and will be assessed under both stimulation (experimental) and non-stimulation (control) conditions.The sample will be one of convenience and will consist of the voluntary participation of 20 adults diagnosed with cerebral palsy who have reduced mobility and are institutionalized at the residence of the Catalan Foundation for Cerebral Palsy (FCPC).The physical exercise program will last for 2 days per week over a period of 12 consecutive weeks, with prior agreement from the center's management and their participation in the study. The 20 participants will be divided into two groups of 10 people. The first group (Group A) will begin the intervention with both the physiotherapy protocol and somatosensory stimulation, while the second group (Group B) will start with the physiotherapy protocol only. At the midpoint of the intervention, in week 6, the groups will switch: Group A will then receive only the physiotherapy protocol, and Group B will begin receiving somatosensory stimulation alongside the physiotherapy protocol. Both groups will continue under these conditions until week 12, marking the end of the intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with a medical diagnosis of cerebral palsy
  • Age: 18-50 years
  • Reduced mobility classified as levels I, II, or III according to the GMFCS
  • Ability to participate in functional assessments with the support of the clinical team
  • Ability to understand informed consent or have a legal representative who can provide consent on their behalf

Exclusion criteria

  • Patients with cerebral palsy who have severe cognitive impairments that hinder understanding of instructions or participation in assessments
  • Adults with cerebral palsy who present with medical conditions that may interfere with the intervention, such as severe cardiovascular disease or major neurological disorders
  • Individuals with cerebral palsy who are participating in another intervention study during the same period

Treatment and study plan

Physical exercise program

Other

The physiotherapy protocol has been developed using the GMFCS scale as a reference. Based on this assessment, each patient's level is determined according to their functional motor abilities, limitations, and use of assistive or mobility devices. Each protocol consists of a total of five exercises: two general exercises and three specific exercises focused on the phases of the corresponding transfer and on skills common to all transfers. Rest periods of 2 minutes and 30 seconds are provided between exercises to ensure adequate recovery and a safe progression. The somatosensory stimulation will consist of intermittent mechanical pressure applied to the skin over the neuromuscular motor points of the quadriceps and gastrocnemius muscles. T

Primary outcomes

  1. Rivermead Mobility Index (RMI)

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

    To evaluate the level of functional mobility, focusing on tasks such as turning over, walking, and climbing stairs.

    0-5 points: severely limited mobility.

    6-10 points: moderately limited mobility.

    11-15 points: mildly limited or good functional mobility.

Secondary outcomes

  1. the Trunk Impairment Scale.

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

    To analyze trunk postural control 0 points: complete absence of trunk control.

    1-7 points: severely impaired trunk control.

    8-15 points: moderately impaired trunk control.

    16-23 points: good trunk control (mild impairment or normal function).

  2. number of repetitions

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

    To evaluate the number of repetitions in the specific exercises of the protocol

  3. The time taken to perform the movement

    Time frame: On the third day after the start of the intervention, in week 6, and in week 12.

    time required for execution and the completeness of the performance.

Study contacts

Contact information is provided by the study sponsor or research team.

Pedro V López Plaza, Director

CONTACT

[email protected]

932 53 32 56

Sponsors and collaborators

Lead sponsor

Facultat de ciencies de la Salut Universitat Ramon Llull

Other

Collaborators

  • Cerebral Palsy Association

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 30, 2025
Registry last updated
Apr 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.